Matthew J. Koster, M.D.

  1. Internist
  2. Rheumatologist

Publications

  1. Ferrada MA, Savic S, Ospina Cardona D, Collins JC, Alessi H, Gutierrez-Rodrigues F, Uthaya Kumar DB, Wilson L, Goodspeed W, Topilow JS, Paik JJ, Poulter JA, Kermani TA, Koster MJ, Warrington K, Cargo CA, Tattersall RS, Duncan CJ, Cantor A, Hoffmann P, Payne EM, Bonnekoh H, Krause K, Cowen EW, Calvo KR, Patel BA, Ombrello AK, Kastner DL, Young NS, Werner A, Grayson PC, Beck DB. Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis. Blood. 2022 Jul 6 Epub 2022 July 06
    View PubMed
  2. Koster MJ, Crowson CS, Giblon RE, Jaquith JM, Duarte-Garcia A, Matteson EL, Weyand CM, Warrington KJ. Baricitinib for relapsing giant cell arteritis: a prospective open-label 52-week pilot study. Ann Rheum Dis. 2022 Jun; 81 (6):861-867 Epub 2022 Feb 21
    View PubMed
  3. Koster MJ, Warrington KJ. ACR and EULAR bring AAV classification into the twenty-first century. Nat Rev Rheumatol 2022 Jun; 18 (6):309-310
    View PubMed
  4. Kaymakci M, Elfishawi M, Alexander MP, Koster MJ, Warrington KJ. Smoldering giant cell arteritis in a coronary artery. Rheumatology (Oxford). 2022 May 28 [Epub ahead of print]
    View PubMed
  5. Heiblig M, Ferrada MA, Koster MJ, Barba T, Gerfaud-Valentin M, Mekinian A, Coelho H, Fossard G, Barraco F, Galicier L, Bienvenu B, Hirsch P, Vial G, Boutin AB, Galland J, Le Guenno G, Bigot A, Warrington KJ, Kermani TA, Grayson PC, Patel BA, Beck D, Jamilloux Y, Fenaux P, Sujobert P. Ruxolitinib is more effective than other JAK Inhibitors to treat VEXAS Syndrome: a retrospective multi center study. Blood. 2022 May 24 [Epub ahead of print]
    View PubMed
  6. Koster MJ, Ghaffar U, Duong SQ, Crowson CS, Burke MM, Viers BR, Potretzke AM, Bjarnason H, Warrington KJ. Incidence, prevalence and mortality of chronic periaortitis: a population-based study. Clin Exp Rheumatol. 2022 May; 40 (4):751-757 Epub 2022 Feb 01
    View PubMed
  7. Hur B, Koster MJ, Jang JS, Weyand CM, Warrington KJ, Sung J. Global Transcriptomic Profiling Identifies Differential Gene Expression Signatures Between Inflammatory and Noninflammatory Aortic Aneurysms. Arthritis Rheumatol. 2022 Apr 11 [Epub ahead of print]
    View PubMed
  8. Kimbrough BA, Warrington KJ, Langenfeld HE, Crowson CS, Carmona EM, Virata AR, Koster MJ. Vasculitis in Patients With Sarcoidosis: A Single-Institution Case Series of 17 Patients. J Clin Rheumatol. 2022 Mar 21 [Epub ahead of print]
    View PubMed
  9. Goyal G, Young JR, Abeykoon JP, Shah MV, Bennani NN, Sartori-Valinotti JC, Vassallo R, Ryu JH, Tobin WO, Koster MJ, Davidge-Pitts CJ, Ravindran A, Rech KL, Go RS. Impact of a Multidisciplinary Tumor Board on the Care of Patients with Histiocytic Disorders: The Histiocytosis Working Group experience. Oncologist. 2022 Mar 4; 27 (2):144-148
    View PubMed
  10. Abeykoon JP, Lasho TL, Dasari S, Rech KL, Ranatunga WK, Manske MK, Tischer A, Ravindran A, Young JR, Tobin WO, Flanagan EP, Nowakowski KE, Ruan GJ, Shah MV, Bennani NN, Vassallo R, Ryu JH, Koster MJ, Davidge-Pitts CJ, Patnaik MM, Wu X, Witzig TE, Goyal G, Go RS, Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group. Sustained, complete response to pexidartinib in a patient with CSF1R-mutated Erdheim-Chester disease. Am J Hematol. 2022 Mar 1; 97 (3):293-302 Epub 2022 Jan 03
    View PubMed
  11. Abeykoon JP, Ravindran A, Rech KL, Young JR, Oliver Tobin W, Shah MV, Nora Bennani N, Vassallo R, Ryu JH, Koster MJ, Davidge-Pitts CJ, Goyal G, Go RS, Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group. Mimics of Erdheim-Chester disease. Br J Haematol. 2022 Feb; 196 (4):984-994 Epub 2021 Nov 20
    View PubMed
  12. Castillejo Becerra CM, Crowson CS, Koster MJ, Warrington KJ, Bhatti MT, Chen JJ. Population-based Rate and Patterns of Diplopia in Giant Cell Arteritis. Neuroophthalmology. 2022; 46 (2):75-79 Epub 2021 Aug 20
    View PubMed
  13. Jin K, Parreau S, Warrington KJ, Koster MJ, Berry GJ, Goronzy JJ, Weyand CM. Regulatory T Cells in Autoimmune Vasculitis. Front Immunol. 2022; 13:844300 Epub 2022 Feb 28
    View PubMed
  14. Hazim AZ, Ruan GJ, Hu M, Ravindran A, Rech KL, Young JR, Cox CW, Abeykoon JP, Scheckel C, Vassallo R, Ryu JH, Tobin WO, Koster MJ, Bennani NN, Shah MV, Goyal G, Go RS, Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group. Langerhans cell histiocytosis with lung involvement in isolation and multisystem disease: Staging, natural history, and comparative survival. Am J Hematol. 2021 Dec 01; 96(12):1604-1610. Epub 2021 Oct 08.
    View PubMed
  15. Garvey TD, Koster MJ, Crowson CS, Warrington KJ. Incidence, survival, and diagnostic trends in GCA across seven decades in a North American population-based cohort. Semin Arthritis Rheum. 2021 Dec; 51 (6):1193-1199 Epub 2021 Sept 27
    View PubMed
  16. Jang JS, Holicky E, Lau J, McDonough S, Mutawe M, Koster MJ, Warrington KJ, Cuninngham JM. Application of the 3' mRNA-Seq using unique molecular identifiers in highly degraded RNA derived from formalin-fixed, paraffin-embedded tissue. BMC Genomics. 2021 Oct 24; 22 (1):759
    View PubMed
  17. Koster MJ, Kourelis T, Reichard KK, Kermani TA, Beck DB, Cardona DO, Samec MJ, Mangaonkar AA, Begna KH, Hook CC, Oliveira JL, Nasr SH, Tiong BK, Patnaik MM, Burke MM, Michet CJ Jr, Warrington KJ. Clinical Heterogeneity of the VEXAS Syndrome: A Case Series. Mayo Clin Proc. 2021 Oct; 96 (10):2653-2659 Epub 2021 Sept 03
    View PubMed
  18. Koster MJ, Warrington KJ. VEXAS within the spectrum of rheumatologic disease. Semin Hematol. 2021 Oct; 58 (4):218-225 Epub 2021 Oct 09
    View PubMed
  19. Thompson GE, Bourne MH Jr, Casal Moura M, Baqir M, Cartin-Ceba R, Makol A, Koster MJ, Warrington KJ, Borah BJ, Specks U. Pleuritis and Pericarditis in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis. Chest. 2021 Aug; 160 (2):572-581 Epub 2021 Mar 02
    View PubMed
  20. Pinto E Vairo F, Koster MJ, Kemppainen JL, Thomas BC, Warrington KJ. Comment on: Anti-tumour necrosis factor treatment for the prevention of ischaemic events in patients with deficiency of adenosine deaminase 2 (DADA2). Rheumatology (Oxford) 2021 Jun 18; 60 (6):e218-e219
    View PubMed
  21. Garvey TD, Koster MJ, Warrington KJ. My Treatment Approach to Giant Cell Arteritis. Mayo Clin Proc. 2021 Jun; 96 (6):1530-1545
    View PubMed
  22. Koster MJ, Crowson CS, Labarca C, Warrington KJ. Incidence and predictors of thoracic aortic damage in biopsy-proven giant cell arteritis. Scand J Rheumatol. 2021 May; 50 (3):239-242 Epub 2020 Sept 17
    View PubMed
  23. Bekele DI, Warrington KJ, Koster MJ. Giant cell arteritis associated with inflammatory bowel disease: a case-series and review of the literature. Rheumatol Int. 2021 Feb; 41 (2):487-492 Epub 2020 Oct 23
    View PubMed
  24. Villatoro-Villar M, Crowson CS, Warrington KJ, Makol A, Koster MJ. Immunoglobulin A vasculitis associated with inflammatory bowel disease: a retrospective cohort study. Scand J Rheumatol. 2021 Jan; 50 (1):40-47 Epub 2020 May 27
    View PubMed
  25. Panda A, Wiseman GA, Koster MJ, Warrington KJ, Johnson GB. (18)F-fluorodeoxyglucose positron emission tomography/computed tomography of giant cell arteritis with lower extremity involvement in association with polymyalgia rheumatica. World J Nucl Med. 2021 Jan-Mar; 20 (1):90-92 Epub 2020 Oct 02
    View PubMed
  26. Hazim AZ, Ruan GJ, Ravindran A, Abeykoon JP, Scheckel C, Vassallo R, Ryu JH, Tobin WO, Koster MJ, Bennani NN, Rech KL, Young JR, Shah MV, Goyal G, Go RS. Efficacy of BRAF-Inhibitor Therapy in BRAF(V600E) -Mutated Adult Langerhans Cell Histiocytosis. Oncologist. 2020 Dec; 25 (12):1001-1004 Epub 2020 Oct 12
    View PubMed
  27. Ungprasert P, Koster MJ, Cheungpasitporn W, Wijarnpreecha K, Thongprayoon C, Kroner PT. Inpatient epidemiology and economic burden of granulomatosis with polyangiitis: a 10-year study of the national inpatient sample. Rheumatology (Oxford). 2020 Dec 1; 59 (12):3685-3689
    View PubMed
  28. Ruan GJ, Hazim A, Abeykoon JP, Scheckel C, Vassallo R, Ryu JH, Tobin WO, Koster MJ, Bennani NN, Rech KL, Young JR, Shah MV, Goyal G, Go RS. Low-dose vemurafenib monotherapy in BRAF(V600E) -mutated Erdheim-Chester disease. Leuk Lymphoma 2020 Nov; 61 (11):2733-2737 Epub 2020 July 01
    View PubMed
  29. Koster MJ, Warrington KJ, Matteson EL. Morbidity and Mortality of Large-Vessel Vasculitides. Curr Rheumatol Rep. 2020 Oct 16; 22 (12):86
    View PubMed
  30. Koster MJ, Yeruva K, Crowson CS, Muratore F, Labarca C, Warrington KJ. Giant cell arteritis and its mimics: A comparison of three patient cohorts. Semin Arthritis Rheum. 2020 Oct; 50 (5):923-929 Epub 2020 June 17
    View PubMed
  31. Sanchez-Alvarez C, Hawkins AS, Koster MJ, Lehman VT, Crowson CS, Warrington KJ. Clinical and Radiographic Features of Giant Cell Arteritis With Intracranial Involvement. ACR Open Rheumatol. 2020 Aug; 2 (8):471-477 Epub 2020 July 22
    View PubMed
  32. Samec MJ, Madrigal AG, Rydberg CH, Koster MJ. Diffuse large B cell lymphoma involving Meckel's cave masquerading as biopsy-negative giant cell arteritis: a case report. J Med Case Rep. 2020 May 10; 14 (1):57
    View PubMed
  33. Kiessling PT, Marinelli JP, Peters PA, DeLone DR, Lane JI, Koster MJ, Carlson ML. Cranial Base Manifestations of Granulomatosis with Polyangiitis. Otolaryngol Head Neck Surg. 2020 May; 162 (5):666-673 Epub 2020 Mar 17
    View PubMed
  34. Coffey CM, Richter MD, Crowson CS, Koster MJ, Warrington KJ, Ytterberg SR, Makol A. Rituximab Therapy for Systemic Rheumatoid Vasculitis: Indications, Outcomes, and Adverse Events. J Rheumatol. 2020 Apr; 47 (4):518-523 Epub 2019 June 15
    View PubMed
  35. Muratore F, Crowson CS, Boiardi L, Pinelli A, Koster MJ, Restuccia G, Kermani TA, Matteson EL, Salvarani C, Warrington KJ. Comparison of biopsy-proven giant cell arteritis in North America and Southern Europe: a population-based study. Clin Exp Rheumatol. 2020 Mar-Apr; 38 Suppl 124 (2):79-83 Epub 2020 Feb 11
    View PubMed
  36. Sanchez-Alvarez C, Koster M, Duarte-Garcia A, Warrington KJ. Disease progression of Takayasu arteritis in two patients treated with tocilizumab. Ann Rheum Dis 2020 Feb; 79 (2):e21 Epub 2018 Dec 08
    View PubMed
  37. Ungprasert P, Koster MJ, Cheungpasitporn W, Wijarnpreecha K, Thongprayoon C, Kroner PT. Inpatient burden and association with comorbidities of polyarteritis nodosa: National Inpatient Sample 2014. Semin Arthritis Rheum. 2020 Feb; 50 (1):66-70 Epub 2019 July 24
    View PubMed
  38. Goyal G, Young JR, Koster MJ, Tobin WO, Vassallo R, Ryu JH, Davidge-Pitts CJ, Hurtado MD, Ravindran A, Sartori Valinotti JC, Bennani NN, Shah MV, Rech KL, Go RS, Mayo Clinic Histiocytosis Working Group. The Mayo Clinic Histiocytosis Working Group Consensus Statement for the Diagnosis and Evaluation of Adult Patients With Histiocytic Neoplasms: Erdheim-Chester Disease, Langerhans Cell Histiocytosis, and Rosai-Dorfman Disease. Mayo Clin Proc. 2019 Oct; 94 (10):2054-2071 Epub 2019 Aug 28
    View PubMed
  39. Villatoro-Villar M, Crowson CS, Warrington KJ, Makol A, Ytterberg SR, Koster MJ. Clinical Characteristics of Biopsy-Proven IgA Vasculitis in Children and Adults: A Retrospective Cohort Study. Mayo Clin Proc. 2019 Sep; 94 (9):1769-1780
    View PubMed
  40. Koster MJ, Yeruva K, Crowson CS, Muratore F, Labarca C, Warrington KJ. Efficacy of Methotrexate in Real-world Management of Giant Cell Arteritis: A Case-control Study. J Rheumatol. 2019 May; 46 (5):501-508 Epub 2019 Jan 15
    View PubMed
  41. Goyal G, Lau D, Nagle AM, Vassallo R, Rech KL, Ryu JH, Davidge-Pitts CJ, Tobin WO, Koster MJ, Bennani NN, Shah MV, Liu MC, Go RS, Mayo Clinic Histiocytosis Working Group. Tumor mutational burden and other predictive immunotherapy markers in histiocytic neoplasms. Blood 2019 Apr 4; 133 (14):1607-1610 Epub 2019 Jan 29
    View PubMed
  42. Kronzer VL, Larson DP, Crowson CS, Warrington KJ, Ytterberg SR, Makol A, Koster MJ. Occurrence and aetiology of gastrointestinal perforation in patients with vasculitis. Clin Exp Rheumatol. 2019 Mar-Apr; 37 Suppl 117 (2):32-39 Epub 2019 Jan 09
    View PubMed
  43. Brennan DN, Ungprasert P, Warrington KJ, Koster MJ. Smoking as a risk factor for giant cell arteritis: A systematic review and meta-analysis. Semin Arthritis Rheum. 2018 Dec; 48 (3):529-537 Epub 2018 July 11
    View PubMed
  44. Villatoro-Villar M, Bold MS, Warrington KJ, Crowson CS, Goyal G, Shah M, Go RS, Koster MJ. Arterial involvement in Erdheim-Chester disease: A retrospective cohort study. Medicine (Baltimore). 2018 Dec; 97 (49):e13452
    View PubMed
  45. Muratore F, Kermani TA, Crowson CS, Koster MJ, Matteson EL, Salvarani C, Warrington KJ. Large-Vessel Dilatation in Giant Cell Arteritis: A Different Subset of Disease? Arthritis Care Res (Hoboken). 2018 Sep; 70 (9):1406-1411 Epub 2018 Aug 12
    View PubMed
  46. Schafer VS, Chrysidis S, Dejaco C, Duftner C, Iagnocco A, Bruyn GA, Carrara G, D'Agostino MA, De Miguel E, Diamantopoulos AP, Fredberg U, Hartung W, Hocevar A, Juche A, Kermani TA, Koster MJ, Lorenzen T, Macchioni P, Milchert M, Dohn UM, Mukhtyar C, Ponte C, Ramiro S, Scire CA, Terslev L, Warrington KJ, Dasgupta B, Schmidt WA. Assessing Vasculitis in Giant Cell Arteritis by Ultrasound: Results of OMERACT Patient-based Reliability Exercises. J Rheumatol. 2018 Aug; 45 (9):1289-1295 Epub 2018 July 01
    View PubMed
  47. Brennan DN, Warrington KJ, Crowson CS, Schmidt J, Koster MJ. Cardiopulmonary involvement in Takayasu's arteritis. Clin Exp Rheumatol. 2018 Mar-Apr; 36 Suppl 111 (2):46-50 Epub 2017 June 12
    View PubMed
  48. Koster MJ, Matteson EL, Warrington KJ. Large-vessel giant cell arteritis: diagnosis, monitoring and management. Rheumatology (Oxford). 2018 Feb 1; 57 (suppl_2):ii32-ii42
    View PubMed
  49. Villatoro-Villar M, Koster MJ. Erdheim-Chester Disease with atrial mass and perinephric calcification. Clin Case Rep. 2017 Dec; 5 (12):2153-2154 Epub 2017 Nov 02
    View PubMed
  50. Koster MJ, Warrington KJ. Vasculitis syndromes: Tocilizumab - a new frontier for GCA therapy. Nat Rev Rheumatol 2017 Dec; 13 (12):700-701 Epub 2017 Sept 07
    View PubMed
  51. Alibaz-Oner F, Koster MJ, Unal AU, Yildirim HG, Cikikci C, Schmidt J, Crowson CS, Makol A, Ytterberg SR, Matteson EL, Direskeneli H, Warrington KJ. Assessment of the frequency of cardiovascular risk factors in patients with Takayasu's arteritis. Rheumatology (Oxford). 2017 Nov 1; 56 (11):1939-1944
    View PubMed
  52. Ungprasert P, Erwin PJ, Koster MJ. Indirect comparisons of the efficacy of biological agents in patients with active ankylosing spondylitis: a systematic review and meta-analysis. Clin Rheumatol. 2017 Jul; 36 (7):1569-1577 Epub 2017 May 28
    View PubMed
  53. Koster MJ, Achenbach SJ, Crowson CS, Maradit-Kremers H, Matteson EL, Warrington KJ. Healthcare Use and Direct Cost of Giant Cell Arteritis: A Population-based Study. J Rheumatol. 2017 Jul; 44 (7):1044-1050 Epub 2017 May 01
    View PubMed
  54. Koster MJ, Warrington KJ. Classification of large vessel vasculitis: Can we separate giant cell arteritis from Takayasu arteritis? Presse Med. 2017 Jul - Aug; 46 (7-8 Pt 2):e205-e213 Epub 2017 July 31
    View PubMed
  55. Alibaz-Oner F, Koster MJ, Crowson CS, Makol A, Ytterberg SR, Salvarani C, Matteson EL, Warrington KJ. Clinical Spectrum of Medium-Sized Vessel Vasculitis. Arthritis Care Res (Hoboken). 2017 Jun; 69 (6):884-891 Epub 2017 Apr 24
    View PubMed
  56. Chan JE, Palakodeti S, Koster MJ. Acute digital ischemia: A rare presentation of antisynthetase syndrome. Eur J Rheumatol. 2017 Mar; 4 (1):63-65 Epub 2017 Mar 01
    View PubMed
  57. Koster MJ, Warrington KJ. Vasculitis of the mesenteric circulation. Best Pract Res Clin Gastroenterol. 2017 Feb; 31 (1):85-96 Epub 2017 Jan 05
    View PubMed
  58. Ungprasert P, Koster MJ, Warrington KJ, Matteson EL. Polymyalgia rheumatica and risk of coronary artery disease: a systematic review and meta-analysis of observational studies. Rheumatol Int. 2017 Jan; 37 (1):143-149 Epub 2016 Aug 30
    View PubMed
  59. Sunjaya DB, Koster MJ, Osborn TG. 61-Year-Old Woman With Systemic Lupus Erythematosus and Chest Pain. Mayo Clin Proc. 2017 Jan; 92: (1)153-158.
    View PubMed
  60. Koster MJ, Warrington KJ. Giant cell arteritis: pathogenic mechanisms and new potential therapeutic targets. BMC Rheumatol. 2017; 1:2 Epub 2017 Nov 28
    View PubMed
  61. Ungprasert P, Wijarnpreecha K, Koster MJ, Thongprayoon C, Warrington KJ. Cerebrovascular accident in patients with giant cell arteritis: A systematic review and meta-analysis of cohort studies. Semin Arthritis Rheum. 2016 Dec; 46 (3):361-366 Epub 2016 July 21
    View PubMed
  62. Ungprasert P, Koster MJ, Thongprayoon C, Warrington KJ. Risk of venous thromboembolism among patients with vasculitis: a systematic review and meta-analysis. Clin Rheumatol. 2016 Nov; 35 (11):2741-2747 Epub 2016 Aug 30
    View PubMed
  63. Koster MJ, Matteson EL, Warrington KJ. Recent advances in the clinical management of giant cell arteritis and Takayasu arteritis. Curr Opin Rheumatol. 2016 May; 28 (3):211-7
    View PubMed
  64. Koster MJ, Warrington KJ, Kermani TA. Update on the epidemiology and treatment of giant cell arteritis. Curr Treatm Opt Rheumatol.2016;2:138-152.
  65. Labarca C, Koster MJ, Crowson CS, Makol A, Ytterberg SR, Matteson EL, Warrington KJ. Predictors of relapse and treatment outcomes in biopsy-proven giant cell arteritis: a retrospective cohort study. Rheumatology (Oxford). 2016 Feb; 55 (2):347-56 Epub 2015 Sept 18
    View PubMed
  66. Lo Gullo A, Koster MJ, Crowson CS, Makol A, Ytterberg SR, Saitta A, Salvarani C, Matteson EL, Warrington KJ. Venous Thromboembolism and Cerebrovascular Events in Patients with Giant Cell Arteritis: A Population-Based Retrospective Cohort Study. PLoS One. 2016; 11 (2):e0149579 Epub 2016 Feb 22
    View PubMed
  67. Koster MJ, Warrington KJ. Recent advances in understanding and treating vasculitis. F1000Res. 2016; 5 Epub 2016 June 20
    View PubMed
  68. Ungprasert P, Koster MJ, Warrington KJ. Coronary artery disease in giant cell arteritis: a systematic review and meta-analysis. Semin Arthritis Rheum. 2015 Apr; 44 (5):586-591 Epub 2014 Oct 29
    View PubMed
  69. Hirai T, Koster M. Osler's nodes, Janeway lesions and splinter haemorrhages. BMJ Case Rep. 2013; 2013:
    View PubMed
  70. Thompson D, Koster MJ, Wagner RH, Heroux A, Barron JT. Single photon emission computed tomography myocardial perfusion imaging to detect cardiac allograft vasculopathy. Eur Heart J Cardiovasc Imaging.13:(3):271-5.
    View PubMed
  71. Ooms LS, Koster MJ, Mitchell JR, Pals-Rylaarsdam R. Identification of a second-site suppressor mutation of the GTPase defect associated with McCune-Albright syndrome: a model using the yeast heterotrimeric G protein, GPA1. Arch Physiol Biochem. 2006 Jul; 112: (3)166-73.
    View PubMed
PST-20216105